SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 462 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,302,749 | +15.3% | 241,823 | +4.6% | 0.08% | +25.4% |
Q2 2023 | $44,490,978 | -5.2% | 231,170 | -0.3% | 0.06% | -10.0% |
Q1 2023 | $46,947,731 | +60.2% | 231,875 | +1.7% | 0.07% | +52.2% |
Q4 2022 | $29,306,448 | -4.9% | 228,048 | +1.3% | 0.05% | -11.5% |
Q3 2022 | $30,818,000 | -23.4% | 225,231 | -1.0% | 0.05% | -18.8% |
Q2 2022 | $40,246,000 | +23.7% | 227,458 | +0.7% | 0.06% | +48.8% |
Q1 2022 | $32,535,000 | -11.6% | 225,862 | -5.1% | 0.04% | 0.0% |
Q4 2021 | $36,790,000 | -7.6% | 237,969 | +1.5% | 0.04% | -15.7% |
Q3 2021 | $39,827,000 | +5.8% | 234,553 | -1.7% | 0.05% | +8.5% |
Q2 2021 | $37,660,000 | +14.0% | 238,536 | +0.2% | 0.05% | +6.8% |
Q1 2021 | $33,043,000 | -21.1% | 237,956 | -0.5% | 0.04% | -25.4% |
Q4 2020 | $41,888,000 | – | 239,166 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |